Detalhe da pesquisa
1.
Identification and validation of m6A-associated ferroptosis genes in renal clear cell carcinoma.
Cell Biol Int
; 48(6): 777-794, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38440906
2.
Clinical, Pathological, and Prognostic Analysis of Urachal Carcinoma.
Urol Int
; 106(2): 199-208, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34515250
3.
Integral Analysis of the RNA Binding Protein-associated Prognostic Model for Renal Cell Carcinoma.
Int J Med Sci
; 18(4): 953-963, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33456353
4.
Eukaryotic translation initiation factor 3 subunit b is a novel oncogenic factor in prostate cancer.
Mamm Genome
; 31(7-8): 197-204, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32556998
5.
The Anticancer Effect of Huaier Extract in Renal Cancer 786-O Cells.
Pharmacology
; 102(5-6): 316-323, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30296782
6.
TERT Promoter Hypermethylation in Gastrointestinal Cancer: A Potential Stool Biomarker.
Oncologist
; 22(10): 1178-1188, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28754720
7.
TERT promoter mutations and TERT mRNA but not FGFR3 mutations are urinary biomarkers in Han Chinese patients with urothelial bladder cancer.
Oncologist
; 20(3): 263-9, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25657201
8.
Laparoscopic pyelotomy combined with ultrasonic lithotripsy via a nephroscope for the treatment of complex renal stones.
Urolithiasis
; 52(1): 22, 2024 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38189842
9.
Renal cell carcinoma presenting as exfoliative dermatitis (erythroderma) - a case report.
Clin Nephrol
; 80(1): 63-6, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22575379
10.
The cuproptosis-associated 11 gene signature as a predictor for outcomes and response to Bacillus Calmette-Guerin and immune checkpoint inhibitor therapies in bladder carcinoma.
Front Immunol
; 14: 1126247, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37207200
11.
Absolute monocyte count has a diagnostic role in distinguishing tumor marker-negative TGCT from benign testicular tumor via CCL2 regulation.
Medicine (Baltimore)
; 102(25): e34114, 2023 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37352031
12.
Dyskerin and telomerase RNA component are sex-differentially associated with outcomes and Sunitinib response in patients with clear cell renal cell carcinoma.
Biol Sex Differ
; 14(1): 46, 2023 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37434223
13.
Widespread genomic/molecular alterations of DNA helicases and their clinical/therapeutic implications across human cancer.
Biomed Pharmacother
; 158: 114193, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36586240
14.
PBRM1 mutation and WDR72 expression as potential combinatorial biomarker for predicting the response to Nivolumab in patients with ccRCC: a tumor marker prognostic study.
Aging (Albany NY)
; 15(23): 13753-13775, 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38048211
15.
Genomic, epigenomic, and transcriptomic signatures for telomerase complex components: a pan-cancer analysis.
Mol Oncol
; 17(1): 150-172, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36239411
16.
The chromosomal instability 25 gene signature is identified in clear cell renal cell carcinoma and serves as a predictor for survival and Sunitinib response.
Front Oncol
; 13: 1133902, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37197417
17.
Activation of telomerase by seminal plasma in malignant and normal cervical epithelial cells.
J Pathol
; 225(2): 203-11, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21590772
18.
SETD8 stabilized by USP17 epigenetically activates SREBP1 pathway to drive lipogenesis and oncogenesis of ccRCC.
Cancer Lett
; 527: 150-163, 2022 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34942305
19.
Berberine enhances gemcitabineinduced cytotoxicity in bladder cancer by downregulating Rad51 expression through inactivating the PI3K/Akt pathway.
Oncol Rep
; 47(2)2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34935059
20.
The cuproptosis-associated 13 gene signature as a robust predictor for outcome and response to immune- and targeted-therapies in clear cell renal cell carcinoma.
Front Immunol
; 13: 971142, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36131921